Reckitt Kept Addiction Drugs Off Market: Antitrust Suit

Law360, New York (February 14, 2013, 3:28 PM EST) -- Drug wholesaler Rochester Drug Co-Operative Inc. hit Reckitt Benckiser Inc. with a proposed class action in Delaware federal court Wednesday, accusing it of an anti-competitive scheme to keep generic rivals to opiate addiction treatment Suboxone off the market.

According to Rochester’s complaint, Reckitt had illegally manipulated the U.S. Food and Drug Administration’s regulatory systems, effectively extending its monopoly over the drug beyond a seven-year exclusivity period granted by the agency, causing purchasers to overpay for the drug.

“Reckitt cannot justify its scheme by pointing to any...
To view the full article, register now.